Stanozolol 100 - Livewell Pharmaceuticals

Stanozolol made its therapeutic debut as Winstrol in 1962, following its discovery and formulation by Winthrop Laboratories. Patented by Sterling in the U.S., it was administered for treating a wide range of conditions including anorexia, trauma-induced muscle loss, and dwarfism. Unique for its oral bioavailability and non-estrogenic profile, it quickly spread in both human and animal medical circles. Though eventually phased out in the U.S., international manufacturing continues today, particularly in injectable format for livestock and athletic animal conditioning.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Stanozolol 100 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.